Thursday, July 11, 2024 12:46:24 PM
And that's the key Gary, " as long as you are correct in the long term". Critical to remain objective and be willing to sell and move on if the original investment basis no longer exists. Years ago, about the same time I began following NWBO, I also was interested in TXMD, another little biotech. Took a position and followed it as they had an existing line of prenatal vitamins, received FDA approval for 2 women's reproductive system drugs and licensed a third. So looked good, but over the next few years it became evident management was incapable of executing a plan and selling the products. Sold, as I had no faith in management, took a small loss, share price was about $6 when I exited. That was several years ago. Since then, the company has done a 1 for 50 reverse split, sold the right to the products to another company and is slowing dying on the royalty fees from those companies.
It's not easy being a long-term investor in a company like NWBO, has required a lot of patience, especially when your investment has been dead money for several years. Regardless, in this case there is enough potential and promise to keep us hanging on.
It's not easy being a long-term investor in a company like NWBO, has required a lot of patience, especially when your investment has been dead money for several years. Regardless, in this case there is enough potential and promise to keep us hanging on.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
